Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2012 | 03-2011 | 03-2010 | 03-2009 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 70 | 14 | N/A | N/A |
| Accounts receivable | 20 | -59 | 2 | -1 |
| Other Working Capital | 11 | -34 | 6 | -17 |
| Other Operating Activity | -74 | 4 | -28 | -32 |
| Operating Cash Flow | $27 | $-75 | $-20 | $-51 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -5 | -633 | N/A | N/A |
| Investing Cash Flow | $-5 | $-633 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | N/A | 400 | 200 |
| Debt Issued | 0 | 575 | N/A | N/A |
| Common Stock Issued | 0 | 8 | N/A | N/A |
| Common Stock Repurchased | N/A | 0 | -25 | -59 |
| Financing Cash Flow | $0 | $583 | $375 | $141 |
| Beginning Cash Position | 399 | 524 | 169 | 79 |
| End Cash Position | 421 | 399 | 524 | 169 |
| Net Cash Flow | $22 | $-125 | $354 | $90 |
| Free Cash Flow | ||||
| Operating Cash Flow | 27 | -75 | -20 | -51 |
| Capital Expenditure | -5 | -633 | N/A | N/A |
| Free Cash Flow | 22 | -708 | -20 | -51 |